engleski

Challenges of technology transfer in the vaccine development process

Technology transfer accelerates successful adoption of innovations. In doing so, it seeks to make the knowledge and technology developed in its public laboratories available to public and private entities in a variety of ways. Technology transfer is a key factor that strongly influences economic growth, both short-term and long-term. Structural changes to the entire economy are almost impossible without effective technology transfer and a well-defined innovation system of the country. The transfer of vaccine technology can have a huge impact on vaccine access and subsequent health improvements. Although vaccines against COVID-19 have developed rapidly, all steps have been taken to ensure their safety and efficacy. It can be concluded that vaccines against COVID-19 were rapidly developed and distributed to help combat the pandemic. The following COVID-19 vaccines are currently approved in the European Union, including the Republic of Croatia - Comirnatym (Australia), Spikevax (Spain), Vaxzevria (UK) and COVID-19 Vaccine Janssen (Belgium). It can be concluded that in all countries producing vaccines for COVID-19 there has been an increase in gross domestic product which can be linked to the interest of countries in procuring the appropriate vaccine to finally bring the pandemic to an end.

technology transfer ; vaccines ; COVID-19 ; end of the pandemic

nije evidentirano